ATE246199T1 - 3-descladinose-2,3-anhydroerythromycin-derivate - Google Patents

3-descladinose-2,3-anhydroerythromycin-derivate

Info

Publication number
ATE246199T1
ATE246199T1 AT97921411T AT97921411T ATE246199T1 AT E246199 T1 ATE246199 T1 AT E246199T1 AT 97921411 T AT97921411 T AT 97921411T AT 97921411 T AT97921411 T AT 97921411T AT E246199 T1 ATE246199 T1 AT E246199T1
Authority
AT
Austria
Prior art keywords
descladinose
anhydroerythromycin
derivatives
anhydroerythromycin derivatives
Prior art date
Application number
AT97921411T
Other languages
English (en)
Inventor
Richard L Elliott
Yat Sun Or
Daniel T Chu
George W Griesgraber
Jacob J Plattner
Daisy Pireh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/832,741 external-priority patent/US5750510A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE246199T1 publication Critical patent/ATE246199T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97921411T 1996-05-07 1997-04-25 3-descladinose-2,3-anhydroerythromycin-derivate ATE246199T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64641896A 1996-05-07 1996-05-07
US08/832,741 US5750510A (en) 1997-04-04 1997-04-04 3-descladinose-2,3-anhydroerythromycin derivatives
PCT/US1997/007051 WO1997042205A1 (en) 1996-05-07 1997-04-25 3-descladinose-2,3-anhydroerythromycin derivatives

Publications (1)

Publication Number Publication Date
ATE246199T1 true ATE246199T1 (de) 2003-08-15

Family

ID=27094927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921411T ATE246199T1 (de) 1996-05-07 1997-04-25 3-descladinose-2,3-anhydroerythromycin-derivate

Country Status (16)

Country Link
EP (1) EP0922050B1 (de)
JP (1) JP2002502366A (de)
KR (1) KR20000011071A (de)
AR (1) AR007021A1 (de)
AT (1) ATE246199T1 (de)
AU (1) AU710532B2 (de)
BR (1) BR9708930A (de)
CA (1) CA2253451A1 (de)
CZ (1) CZ349698A3 (de)
DE (1) DE69723848T2 (de)
DK (1) DK0922050T3 (de)
ES (1) ES2203800T3 (de)
IL (1) IL126624A0 (de)
NZ (1) NZ332321A (de)
PT (1) PT922050E (de)
WO (1) WO1997042205A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
MXPA00009619A (es) 1998-04-02 2006-03-09 Targacept Inc Composiciones farmaceuticas y metodos de uso.
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
US20010031771A1 (en) 1999-05-24 2001-10-18 Gary Maurice Dull Pharmaceutical compositions and methods for use
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
ES2278319T3 (es) * 2003-05-13 2007-08-01 Glaxo Group Limited Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2009106419A1 (en) 2008-02-08 2009-09-03 Basilea Pharmaceutica Ag New macrolides and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
IL126624A0 (en) 1999-08-17
DK0922050T3 (da) 2003-11-24
EP0922050A1 (de) 1999-06-16
JP2002502366A (ja) 2002-01-22
CA2253451A1 (en) 1997-11-13
DE69723848D1 (en) 2003-09-04
AU710532B2 (en) 1999-09-23
AR007021A1 (es) 1999-10-13
CZ349698A3 (cs) 1999-04-14
AU2745397A (en) 1997-11-26
NZ332321A (en) 2000-04-28
ES2203800T3 (es) 2004-04-16
PT922050E (pt) 2003-12-31
EP0922050B1 (de) 2003-07-30
BR9708930A (pt) 1999-08-03
WO1997042205A1 (en) 1997-11-13
KR20000011071A (ko) 2000-02-25
DE69723848T2 (de) 2004-07-01

Similar Documents

Publication Publication Date Title
PT901474E (pt) Derivados de aril-pirimidina.
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
ATE261942T1 (de) 6-phenylpyridinderivate
BR9700688A (pt) 2-oxo- e 2-tio-1,2-dihidroquinolinil-oxazolidinonas
IS4800A (is) Nýjar 19-nor-pregnene afleiður
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO981946D0 (no) Imidazoquinazolin-derivater
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
PT931087E (pt) Novos derivados de piranosido
TR28915A (tr) Naftokinon türevleri.
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
TR199700927A3 (tr) N-Benzilazolyum türevleri.
FI963062A0 (fi) Dubbelblad foer stoetblad, skopa, schaktblad
FI962118A0 (fi) Foerbaettrad anordning foer behandling av roekgaser, saerskilt avgaser
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
FI963155A0 (fi) Diconelaserreaktor, Arringsstaelle med tryckturbin, Diconefusionsaccelerator (dubbelkon)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0922050

Country of ref document: EP

REN Ceased due to non-payment of the annual fee